NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

PI Industries Stock Takes a Hit as Custom Synthesis Business Continues to Struggle

PI Industries, a leading agrochemicals maker, has seen its stock plummet by 11% over the past two trading sessions, a clear indication of the ongoing pressure in its custom synthesis and manufacturing (CSM) business. This segment, which accounts for the bulk of the company's revenue, has now experienced a year-over-year decline for five consecutive quarters.

The CSM segment, a critical contributor to PI Industries' revenue, has seen its performance deteriorate significantly. While it contributed approximately 75% of the company's FY26 revenue of ₹6,714 crore, its revenue has fallen by 16% year-on-year. This decline is a cause for concern, as it indicates a sustained trend of weakness in the segment.

SegmentFY26 Revenue
Custom Synthesis and Manufacturing (CSM)₹5,012 crore (75% of FY26 revenue)
Year-over-Year Change in CSM Revenue-16%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Note: FY26 revenue for PI Industries is ₹6,714 crore.

Investor Takeaway

Investors should be cautious about the company's core business weakening.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.